Europe’s illicit drug market is undergoing a rapid shift, with synthetic opioids emerging as a concern, although the region still experiences far fewer fatal overdoses than North America, the European Union Drugs Agency stated in its annual report.
The Lisbon-based agency, drawing on data from the 27 EU member states, Norway and Turkey, noted that at least 50 new psychoactive substances were
